Computational and Synthetic approach with Biological Evaluation of Substituted Quinoline derivatives as small molecule L858R/T790M/C797S triple mutant EGFR inhibitors targeting resistance in Non-Small Cell Lung Cancer (NSCLC)-Reference-Cited by-同舟云学术

Computational and Synthetic approach with Biological Evaluation of Substituted Quinoline derivatives as small molecule L858R/T790M/C797S triple mutant EGFR inhibitors targeting resistance in Non-Small Cell Lung Cancer (NSCLC)

Published:2021-02 Issue: Volume:107 Page:104612
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Karnik Kshipra S.,Sarkate Aniket P.,Tiwari Shailee V.,Azad Rajaram,Burra Prasad V.L.S.,Wakte Pravin S.

Funder

Indian Council of Medical Research

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference45 articles.

1. Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trial;Voldborg;Ann. Oncol.,1997

2. Protein tyrosine kinases and cancer;Kolibaba;BBA,1997

3. Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor;Stamos;J. Biol. Chem.,2002

4. Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains;Ogiso;Cell,2002

5. Critical Update and Emerging Trends in Epidermal Growth Factor Receptor Targeting in Cancer;Baselga;J. Clin. Oncol.,2005

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and synthesis of novel Thiazolo[5,4-b]pyridine derivatives as potent and selective EGFR-TK inhibitors targeting resistance Mutations in non-small cell lung cancer;European Journal of Medicinal Chemistry;2024-10

2. Design, synthesis, and biological evaluation of novel 2,3-Di-O-Aryl/Alkyl sulfonate derivatives of l-ascorbic acid: Efficient access to novel anticancer agents via in vitro screening, tubulin polymerization inhibition, molecular docking study and ADME predictions;Bioorganic Chemistry;2024-06

3. Coumarin as an Elite Scaffold in Anti-Breast Cancer Drug Development: Design Strategies, Mechanistic Insights, and Structure–Activity Relationships;Biomedicines;2024-05-27

4. Development of Potential Antidiabetic Agents Using 2D and 3D QSAR, Molecular Docking and ADME Properties In-silico Studies of α-Amylase Inhibitors;Letters in Drug Design & Discovery;2024-02-21

5. Computational and Synthetic Approach with Biological Evaluation of Substituted Thiazole Derivatives as Small Molecule L858R/T790M/C797S Triple Mutant EGFR Inhibitors Targeting Resistance in Non-Small Cell Lung Cancer (NSCLC);2024-02-19